Q2 2017 PDL BioPharma Inc Earnings Call
Conference Call PDL BioPharma Inc
PDL BioPharma Inc Conference call or earnings call will be held on Aug 3, 2017 During the earnings conference call's session PDL BioPharma Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact PDL BioPharma Inc for this information
Schedule a conference call with QCONF and get 5 free conference calls.
PDL manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents, license agreements with various biotechnology and pharmaceutical companies, and royalty and other assets acquired. To acquire new income generating assets, PDL provides non-dilutive growth capital and financing solutions to late-stage public and private healthcare companies and offers immediate financial monetization of royalty streams to companies, academic institutions, and inventors. PDL has committed over $1 billion and funded approximately $937 million in these investments to date. PDL evaluates its investments based on the quality of the income generating assets and potential returns on investment. PDL is currently focused on acquiring new income generating assets, the management of its intellectual property and income generating assets and maximizing value for its stockholders. The Company was formerly known as Protein Design Labs, Inc.Read more Conference Call